Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NasoNeb Delivery of Budesonide for Perennial Allergic Rhinitis
NCT01270256Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Jan 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of budesonide in perennial allergic rhinitis (PAR), sponsored by University of Chicago. Started Jan 2011; status: completed.
02
Drugs
budesonide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01270256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270256.